"Cancer services at Rush are ranked among the best in the country by U.S. News & World Report."

During the past decade, Rush University Medical Center, Division of Hematology & Oncology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rush University Medical Center, Division of Hematology & Oncology" #1 sponsor was "Celgene" with 1 trials, followed by "Celgene Corporation" with 1 trials sponsored, "Pfizer" with 1 trials sponsored, "Rush University Medical Center" with 1 trials sponsored and "Sunesis Pharmaceuticals" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Rush University Medical Center, Division of Hematology & Oncology" are "Multiple Myeloma" (2 trials), "Acute Myeloid Leukemia" (1 trials), "Metastatic Breast Cancer" (1 trials) and "Non Small Cell Lung Cancer (NSCLC)" (1 trials). Many other conditions were trialed in "Rush University Medical Center, Division of Hematology & Oncology" in a lesser frequency.

Most popular intervention types in "Rush University Medical Center, Division of Hematology & Oncology" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "A (Thalidomide + Dexamethasone)" (1 trials), "Alclometasone cream" (1 trials), "B (Placebo + Dexamethasone)" (1 trials), "CC-5013" (1 trials) and "Dacomitinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rush University Medical Center, Division of Hematology & Oncology" are 4 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Rush University Medical Center, Division of Hematology & Oncology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Rush University Medical Center, Division of Hematology & Oncology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Rush University Medical Center, Division of Hematology & Oncology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".